Robotic Ankle Therapy for Cerebral Palsy
Trial Summary
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications, but it does mention that you cannot have concurrent treatment other than those assigned during the study. It's best to discuss your specific medications with the trial coordinators.
What data supports the effectiveness of the treatment Robotic Ankle Therapy for Cerebral Palsy?
Research shows that robotic ankle training can improve strength, motor control, and gait function in children with cerebral palsy, as seen in studies using devices like the ATLAS2030 and Rutgers Ankle CP. These improvements suggest that robotic ankle therapy may be effective in enhancing mobility and quality of life for children with cerebral palsy.12345
Is robotic ankle therapy safe for humans?
How is the Biomotum Spark robotic ankle therapy different from other treatments for cerebral palsy?
The Biomotum Spark robotic ankle therapy is unique because it provides both assistance and resistance to the ankle, which can help improve strength and motor control in children with cerebral palsy. This approach is different from traditional therapies as it uses a robotic exoskeleton to enhance ankle function, potentially leading to better gait and overall mobility.236910
What is the purpose of this trial?
The first specific aim is to quantify improvement in ankle muscle function and functional mobility following targeted ankle resistance gait training in ambulatory children with cerebral palsy (CP). The primary hypothesis for the first aim is that targeted ankle resistance training will produce larger improvements in lower-extremity motor control, gait mechanics, and clinical measures of mobility assessed four- and twelve-weeks post intervention compared to standard physical therapy and standard gait training. The second specific aim is to determine the efficacy of adaptive ankle assistance to improve capacity and performance during sustained, high-intensity, and challenging tasks in ambulatory children with CP. The primary hypothesis for the second aim is that adaptive ankle assistance will result in significantly greater capacity and performance during the six-minute-walk-test and graded treadmill and stair stepping protocols compared to walking with ankle foot orthoses and walking with just shoes.
Research Team
Zach F Lerner, PhD
Principal Investigator
Northern Arizona University
Eligibility Criteria
This trial is for children aged 8-18 with Cerebral Palsy who have trouble walking due to ankle issues. They must be able to follow simple instructions and walk at least 30 feet, with or without help. Kids who've had other treatments or surgeries within the last 6 months can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo targeted ankle resistance gait training and adaptive ankle assistance for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Ankle foot orthosis
- Biomotum Spark: Robotic ankle assistance
- Biomotum Spark: Robotic ankle resistance
- Standard gait training
- Standard physical therapy
- Standard walking
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northern Arizona University
Lead Sponsor
University of Washington
Collaborator
Gillette Children's Specialty Healthcare
Collaborator